Image
Back to top
Prof Diamant Thaçi
Director and Professor at the Institute and Comprehensive Centre for Inflammation Medicine
Professor Diamant Thaçi is Director and Professor at the Institute and Comprehensive Centre for Inflammation Medicine, University of Lübeck, Germany. Professor Thaçi is also Chairman of the Inflammatory Board at the University Hospital Schleswig-Holstein, Lübeck Campus.
He is an active member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Psoriasis Council (IPC), the International Eczema Council (IEC), and the Skin Inflammation & Psoriasis International Network (SPIN). His research interests cover immunological work in basic research and all stages of clinical drug development, with a focus on chronic inflammatory skin diseases.
0 resources
You are currently seeing only Dermatology content
File
Support patients with this wound care guide including practical tips, dressing pros/cons and guidance for routine HS lesions
EU-DA-2500084
File
Master the new S2k HS guidelines. Download this quick guide for key updates and printable treatment algorithms to optimise patient care
EU-BK-2500037
Image
Video41:11 min
Navigating the new European S2k guidelines for hidradenitis suppurativa: How will they change your clinical practice?
Unlock the European S2k HS guidelines. Prof. Tzellos and Prof. Bechara share expert insights and implications of the updated guidelines
EU-BK-2500021
Image
Video6:55 min
Setting up MDT care in HS: Learning from psoriasis
Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare
EU-DA-2400507
Image
Video6:30 min
Use of imaging in HS management
Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation
EU-DA-2400506
Image
Video4:25 min
Evidence-based approach to medical management based on the European guidelines for HS
Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy
EU-BK-2400332